KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer (Q37023905)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer |
scientific article |
Statements
1 reference
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer (English)
1 reference
N Nakayama
1 reference
K Nakayama
1 reference
S Yeasmin
1 reference
M Ishibashi
1 reference
A Katagiri
1 reference
K Iida
1 reference
M Fukumoto
1 reference
K Miyazaki
1 reference
18 November 2008
1 reference
1 reference
2020-2028
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference